CD40LG and COVID-19: However, with the emergence of the first results of immunological studies of Chinese COVID-19 patients [5], [6], [7], [8], and the development of specific anti-SARS-CoV-2 IgM/IgG serological assays [9] it may now be possible to study immune responses more closely.